IART Stock Analysis: Buy, Sell, or Hold?
IART - Integra LifeSciences Holdings
$16.65
-0.47 (-2.75%)
▼
5d:
-15.87%
30d:
-6.93%
90d:
+57.97%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IART is down 15.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IART is down 15.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.62
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$10.94
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $16.65, which is considered oversold relative to its 30-day fair value range of $17.59 to $19.23. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.4) compared to its historical average (5.3). At these levels, the market is pricing in 6.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a strong uptrend. Immediate support is located at $16.04, while resistance sits at $20.49.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.56 (+17.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IART is in a strong uptrend. Immediate support is located at $16.04, while resistance sits at $20.49.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.56 (+17.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$17.59 -
$19.23
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
Protect Your Profits
Holding IART? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.56)
- BEARISH: Market expects 6.6% growth - appears too optimistic based on history
- WARNING: Recommendation downgraded due to -15.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$17.59 -
$19.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.04
Resistance Level
$20.49
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.39
Wall Street Target
$19.56
(+17.5%)
Revenue Growth (YoY)
0.8%
Earnings Growth (YoY)
0.4%
Profit Margin
-0.4%
Valuation Premium vs History
+6.6% premium
PE vs Historical
6.4 vs 5.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.6%
(market-implied from PE analysis)
1-Year Target
$17.75
(+7%)
2-Year Target
$18.92
(+14%)
3-Year Target
$20.17
(+21%)
3-Yr Target (if PE normalizes)
(PE: 6→5)
PE COMPRESSION
$16.73
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 6.0%)
$64.37
(+287%)
Base:
(SPY PE: 6.4, Growth: 6.0%)
$19.85
(+19%)
Bear:
(PE: 5.3, Growth: 6.0%)
$16.46
(-1%)
Share & Embed Analysis
Last updated: August 02, 2026 11:50 AM ET
Data refreshes hourly during market hours. Next update: 12:50 PM
Data refreshes hourly during market hours. Next update: 12:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
Advanced IART Option Strategies
Professional options setups generated by AI based on today's IART price and gamma walls.
